Dalfampridine
7 NDCs across 7 manufacturers|7 Generic,0 Brand
Dalfampridine is used to treat neurologic gait disorders and multiple sclerosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 22, 2010, and the first generic was approved Jan 23, 2017. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $89 million on Dalfampridine across 117,000 claims for 18,000 beneficiaries.
Dalfampridine is available as 7 NDCs from 7 manufacturers (7 generic, 0 brand), with NADAC prices from $0.40 to $0.46 per EA — a 16% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
7
7G / 0B
Manufacturers
7
competing in market
Price Spread
$0.40 – $0.46
per EA
7d Activity
avg -9.5% WoW · of 7 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Aurobindo Pharma Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Potassium Channel Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
7 manufacturers producing DALFAMPRIDINE(2 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DALFAMPRIDINE ER 10 MG TABLET | $0.4583 per EA | — |
DALFAMPRIDINE ER 10 MG TABLET | $0.3992 per EA | -9.49% |
DALFAMPRIDINE ER 10 MG TABLET | $0.3992 per EA | -9.49% |
DALFAMPRIDINE ER 10 MG TABLET | $0.3992 per EA | -9.49% |
DALFAMPRIDINE ER 10 MG TABLET | $0.3992 per EA | -9.49% |
DALFAMPRIDINE ER 10 MG TABLET | $0.3992 per EA | -9.49% |
DALFAMPRIDINE ER 10 MG TABLET | $0.3962 per EA | — |
Frequently Asked Questions
What is Dalfampridine used to treat?
Dalfampridine is used to treat neurologic gait disorders and multiple sclerosis, per the National Library of Medicine's MED-RT classification.
When did Dalfampridine become available as a generic?
FDA approved the first generic Dalfampridine (ANDA) on Jan 23, 2017. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Dalfampridine?
In 2024, Medicare Part D spent $89 million on Dalfampridine across 117,000 claims for 18,000 beneficiaries.
How many Dalfampridine products are on the market?
The Dalfampridine drug market contains 7 NDCs from 7 manufacturers — 7 generic and 0 brand products.
What is the price range for Dalfampridine?
NADAC reference prices for Dalfampridine range from $0.3962 to $0.4583 per EA — a 16% difference between cheapest and most expensive.
Which manufacturers make Dalfampridine?
7 manufacturers list Dalfampridine in NADAC. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (1), Accord Healthcare Inc. (1), Micro Labs Limited (1), Actavis Pharma, Inc. (1), CivicaScript LLC (1).
How has the price of Dalfampridine changed recently?
Over the past 7 days, 0 Dalfampridine NDCs rose and 5 fell, with a market-wide average change of -9.5%.